Publicacións en colaboración con investigadores/as de Universidade de Santiago de Compostela (208)

2024

  1. Cough severity visual analog scale scores and quality of life in patients with refractory or unexplained chronic cough

    Respiratory Investigation, Vol. 62, Núm. 6, pp. 987-994

  2. Diabetes and obstructive sleep apnoea: A case-control study

    Medicina Clinica, Vol. 162, Núm. 2, pp. 49-55

  3. Effect of an intensive tobacco cessation program on the smoker narrative: A content analysis and grounded theory

    Tobacco Induced Diseases, Vol. 22

  4. Evolution of smoking prevalence in Spain and its 17 autonomous regions (1987-2020)

    Medicina Clinica, Vol. 162, Núm. 9, pp. 417-424

  5. Exploring CD26−/lo subpopulations of lymphocytes in asthma phenotype and severity: A novel CD4+ T cell subset expressing archetypical granulocyte proteins

    Allergy: European Journal of Allergy and Clinical Immunology

  6. New Vaccines for Chronic Respiratory Patients

    Archivos de Bronconeumologia, Vol. 60, Núm. 9, pp. 565-575

  7. Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study

    Inflammopharmacology, Vol. 32, Núm. 4, pp. 2305-2315

  8. Pediatric Inferior Turbinate Hypertrophy: Diagnosis and Management. A YO-IFOS Consensus Statement

    Laryngoscope, Vol. 134, Núm. 3, pp. 1437-1444

  9. Relationship between obstructive sleep apnea and type 2 diabetes mellitus

    Medicina Clinica, Vol. 162, Núm. 8, pp. 363-369

  10. Reliability of large language models in managing odontogenic sinusitis clinical scenarios: a preliminary multidisciplinary evaluation

    European Archives of Oto-Rhino-Laryngology

  11. SEPAR Guidelines for Pharmacological Treatment of Tobacco Dependence 2023: New Contributions in Daily Clinical Practice

    Open Respiratory Archives

  12. Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 79, Núm. 3, pp. 656-666

  13. The role of traditional NSAIDs and selective COX-2 inhibitors on COVID-19 outcomes: a real-world data study

    Inflammopharmacology

  14. Usefulness of a predictive model to hospitalize patients with low-risk community-acquired pneumonia

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 1, pp. 61-71